Laboratory Reference Grade Compounds
Healing & Tissue Repair Peptides

BPC-157

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,800.00
Low Stock (3)
Net Content10MG
InclusionVial Only
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose250 mcg – 500 mcg dailySyringe: 5.0 units (0.05 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
BPC-15710MG · Vial Only
₱2,800.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: BPC-157 (Body Protection Compound-157) is a peptide composed of 15 amino acids, originally discovered in natural gastric digestive juices where it protects stomach tissue from acid and enzymes.

How it works: In laboratory models, BPC-157 stimulates the formation of fresh microvascular blood vessels (angiogenesis) by activating early growth response-1 (egr-1) and VEGF receptor pathways. It also activates nitric oxide (eNOS) production to improve local blood flow, while upregulating collagen synthesis and cell migration directly at damaged tissue sites.

Why researchers study it: Studied extensively for accelerating tendon, ligament, muscle, and gut lining healing, reducing systemic inflammation, and protecting gastrointestinal integrity from injury and ulceration.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryTissue Repair & Healing
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number137525-51-0
PubChem CID9941957↗
Molecular Weight1419.53 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options2MG, 5MG, 10MG, 20MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaGly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)
⚡ Pharmacodynamic Synergy·Verified Stacking Regimens

Frequently Stacked with BPC-157 (Pentadecapeptide)

Clinically verified combinations activating complementary physiological pathways without receptor competition.

Stacking Studio
Co-Administered Regimen

TB-500 (Thymosin Beta-4 Frag)

+98 Synergy
The Wolverine Stack: Dual Microvascular & Actin Remodeling Synergy

BPC-157 acts locally by accelerating microvascular angiogenesis via VEGFR2 and stabilizing granulation tissue, while TB-500 sequesters G-actin to drive rapid systemic cell migration and prevent fibrous adhesion/scar formation.

⏱In-vitro assay titration protocol•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

GHK-Cu (Copper Tripeptide-1)

+93 Synergy
Microvascular & Extracellular Matrix Remodeling Synergy

BPC-157 rapidly generates fresh capillary networks (angiogenesis) to deliver oxygen and amino acids to damaged tissue, while GHK-Cu signals fibroblasts to synthesize new type I/III collagen and elastin while inhibiting TGF-beta scar formation.

⏱Administer in separate SubQ injections daily•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

Tirzepatide

+91 Synergy
Incretin GI Tolerance & Mucosal Cytoprotection Stack

GLP-1 receptor agonists can cause transient delayed gastric emptying, nausea, and mucosal irritation. BPC-157 provides direct cytoprotective benefits across gastric epithelium, reducing gut discomfort while incretins drive metabolic weight loss.

⏱Tirzepatide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare
Co-Administered Regimen

Semaglutide

+90 Synergy
GLP-1 Gut Barrier & Epithelial Recovery Stack

Semaglutide delays gastric motility to enhance satiety. BPC-157 upregulates tight junction proteins (Claudin, Zonula Occludens) and nitric oxide synthesis, minimizing digestive cramping and acid reflux in GLP-1 naive subjects.

⏱Semaglutide: Weekly SubQ•🛡Separate syringe
15% Off bundle
Compare